First New York patient cured of sickle cell disease using Lyfgenia gene therapy
Summary
Sebastien Beauzile, a 21-year-old living with sickle cell anemia, has become the first person in New York State to be cured of the disease using Lyfgenia, a gene therapy that reprograms bone marrow to produce healthy red blood cells. The treatment, administered at Cohen Children's Medical Center on Long Island, has eliminated his chronic pain and transformed his life after two decades of suffering.
Source
Key quotes
· 3 pulledSince gene therapy, I haven't had any pain.
For 21 years, Sebastien Beauzile lived with a disease that shaped every part of his existence.
Doctors at Cohen Children's Medical Center on Long Island gave him a single infusion that changed all of that.
You might also wanna read
First In-Vivo Gene-Editing Therapy Successfully Saves Newborn's Life in 2025
In 2025, doctors and scientists in the U.S. successfully performed the world's first custom gene-editing therapy inside a living person—a ne
WHO publishes first global guidelines for managing sickle-cell disease in children and adolescents
This article presents the first WHO normative guideline on the diagnosis, prevention, and clinical management of sickle-cell disease (SCD) i
Columbia Researcher Discovers Rare Genetic Mutation That Provides Universal Antiviral Immunity
Columbia University immunologist Dusan Bogunovic discovered that a rare genetic mutation causing immune deficiency in some patients also gra
Seventh Person Cured of HIV Through Stem Cell Transplant, Second Without HIV-Resistant Cells
A man has become the seventh person to be cured of HIV after receiving a stem cell transplant for blood cancer treatment. Significantly, he

FDA Approves First Dual-AAV Gene Therapy for Genetic Hearing Loss Under Priority Voucher Program
The FDA has approved Otarmeni (lunsotogene parvec-cwha), the first-ever dual adeno-associated virus (AAV) vector-based gene therapy for trea
:max_bytes(150000):strip_icc()/Lucia-Adarve-1-052726-814818be82af48b398a3ee0c268696fd.jpg)
